Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes
- 1 October 2002
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 64 (7) , 1151-1156
- https://doi.org/10.1016/s0006-2952(02)01226-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Propofol-induced cytochrome P450 inhibitionLife Sciences, 2001
- Propofol decreases the clearance of midazolam by inhibiting CYP3A4: An in vivo and in vitro studyClinical Pharmacology & Therapeutics, 1999
- CYTOCHROME P-450 3A4: Regulation and Role in Drug MetabolismAnnual Review of Pharmacology and Toxicology, 1999
- Effects of propofol on human hepatic microsomal cytochrome P450 activitiesXenobiotica, 1998
- Difference between in vivo and in vitro effects of propofol on defluorination and metabolic activities of hamster hepatic cytochrome P450-dependent mono-oxygenasesBritish Journal of Anaesthesia, 1995
- Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and MethoxyfluraneAnesthesiology, 1993
- Inhibitory Effects of Propofol on Cytochrome P450 Activities in Rat Hepatic MicrosomesAnesthesia & Analgesia, 1993
- Alfentanil infusion in total intravenous anaesthesia (TIVA). Population pharmacokinetics fails to predict plasma concentration of alfentanilActa Anaesthesiologica Scandinavica, 1992
- PROPOFOL INHIBITS ENZYMATIC DEGRADATION OF ALFENTANIL AND SUFENTANIL BY ISOLATED LIVER MICROSOMES IN VITROBritish Journal of Anaesthesia, 1992
- Disposition kinetics of propofol during alfentanil anaesthesiaAnaesthesia, 1988